Zylox-Tonbridge Medical Technology (HKG: 2190), a China-based developer of nerve and peripheral vascular interventional devices, has announced the completion of patient enrollment in a multi-center clinical study for its ZENFLEX peripheral vascular stent system in Germany. The study has reached its target of 100 patients.
This prospective, multi-center, single-arm study is designed to evaluate the efficacy and safety of the ZENFLEX system when used to assist in angioplasty for the treatment of peripheral arterial diseases. Notably, this post-marketing follow-up study is conducted in compliance with European Union (EU) regulations.- Fineline.com
